good everyone. highlights evening to for the of first start with I XXXX. financial want and quarter Prahlad, Thanks the
metrics. a served of providing provide financial finish our Next, on how I'll markets other thinking color brief by end I'll we the rest detail are additional and update some about on XXXX. on
the quarter to results. Turning first
grew acquisition continue revenue pleased strength a $XXX be Reported in of impact. quarter exchange and headwind the net revenue X% We in the first had as to a business foreign our million, X%. included organic with approximately negligible
a organically, to created the some the line process representing highlighted the shutdown a the organically of of our export-controlled geographies Analytical Discovery on X% in headwind growth discussed which quarter. an initial based I in our year. guidance our for X% reproductive U.S. in quarter, the grew grew Solutions government into grew a temporary As approval X% in biotech moment. lines. product, delay and color in Both assumptions applied sales broad genomics Diagnostics in and representing pharma both total end strength business sales across segments heading health, provide with for led immunodiagnostics market. previous will XX% by & by total businesses driven additional XX%
a geographic APAC and in on growth by revenue in organic organic revenue was was High decline in As single-digit offset growth single-digit modestly basis. growth Americas single-digit expected, the organic a mixed low revenue Europe. organic revenue mid
impact and the the Excluding up APAC government were from both the to China due revenue lost U.S. shutdown high single-digits.
our by and basis operational quarter Adjusted expanded were basis XXX good the points to first encouraged Adjusted in XX.X%. are gross to driven our in quarter. points operating margins productivity XX.X%, up We business by margins strong first leverage. Diagnostics the performance operating expense in XXX
adjusted versus comprised January. was from more of greater the increase margins. As guidance of favorable growth per and organic XX% $X.XX better The earnings share Rob of our was incremental $X.XX was mentioned, beat and first an from $X.XX revenue than quarter $X.XX of in XXXX
the XXXX, first the Looking quarter start of our Diagnostics with further into key segments business. let's our within drivers for
momentum our grew driven remarks, driven remain low our by on organically by Reproductive grew organic earlier revenue EUROIMMUN and genomics portfolio. by in double-digit testing organically, based across track double single-digits genomics year-over-year high broad my our testing mentioned business. Tulip. in organic in business As double-digits revenue to Immunodiagnostics growth We XXXX. in grew health X%, led
As and about answer U.S. over the portfolio. excited to increasingly single-digit, mentioned, we're products genomics of automated grew progress our sample the customers years. Applied high by MPIs couple future next as on in rely Prahlad our encouraged our
initial total on our Vanadis installations have adopters the Finally, the and of year. the XX we end encouraged remain from feedback track by are by early to
Discovery Analytical to & Turning Solutions.
was timing first by The unique quarter impacted several items.
fourth single-digit of high growth lines. our double-digit screening imaging remained revenue portfolio in pharma leading in in robust, vivo high-content confident product the feel Demand product marks by biotech. XXXX. experienced organic for we will our our mid-single growth We organic revenue consecutive and solutions. detection grow digits However, imaging Discovery led business in quarter and This our
will leading improve few talk We I our will in help leading Discovery a minutes, -- Cisbio, portfolio which are Discovery optimistic that further further our about portfolio.
revenue and been end the revenue a shutdown. off markets two been delays. single-digits, Academic single-digit organic Applied government. business Additionally, and shutdown off digits U.S. were had government impact service growth most in our business growth we our XXXX excluding government, grew mid-single which low government revenue would quarter would decline OneSource and have flat the and U.S. informatics and first timing The difficult experienced high a in markets, double-digit flat from the base, have small impacted which excluding applied, organic a timing by academic comparison.
our driven Looking approximately quarter at items, approximately adjusted tax and below-the-line items. interest rate discrete other for XX%, expense net the first was $XX adjusted by million was and
was uses debt-to-adjusted-EBITDA to is to sheet. Turning adjusted million seasonal the with difference Working inventory and of of capital cash to free times. adjusted million builds. acquisitions. the The Free mostly finished increased and a quarter Tulip flow due the $XXX quarter the and reported the flow payments negative number net $X We balance in was quarter of cash. cash X.X associated exited with debt million. and the Vanadis between cash due the billion ratio in $XX with approximately $X.X quarter negative We approximately
our We forecast plan free flow have ongoing flow full actions to year to XXXX. adjusted and of conversion cash execute we in XX% cash continue
As our we million. approximately purchase acquisition at Cisbio, are Rob mentioned, about price excited of of net $XXX
about double-digit in We revenue on by expect XXXX. $XX year return invested four. had Cisbio million of a capital
contribute revenue share to approximately per XXXX, the of we and adjusted earnings $X.XX of Cisbio $XX PerkinElmer. expect For remainder million in to
first the quarter revenue raising of and we outlook strong and our our adjusted for earnings Given addition are Cisbio, results XXXX.
X% growth. from $X.XX billion, to year for revenue organic $XX headwinds, of the million Cisbio million foreign revenue contributions exchange be and including $XX expect We from approximately
driven other adjusted $X.XX in guidance to points, of basis $X.XX, Implicit EPS the year, and expect this expansion addition and of -- For by to a margin of $XX the of million XX%. Cisbio. is, adjusted operating EPS we primarily of rate tax full XXX expense XXX interest
share be our expect We million under XXX to count shares. slightly
Cisbio. $XXX forecasting $XX and revenue exchange For X% headwind of million, including million comparable revenue foreign the reported we quarter are million a XXXX, period of X% to from the of versus representing $X growth, prior second approximately organic
per forecasting we at guidance, This we my remarks. would adjusted time, concludes the In for open questions. share terms earnings Operator, like are this prepared to of call $X.
